Sutro Biopharma, Inc 10-Q for FY2022 Q3
Sutro Biopharma, Inc. (STRO)
10-Q
2022-11-08
For: 2022-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Sutro Biopharma, Inc filed this 10-Q on November 8, 2022, covering the quarter ended September 30, 2022 (FY2022 Q3).
Headline figures
Quarter ended September 30, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $25.15M
- up 195.3% from $8.52M a year earlier
- Net loss
- $19.49M
- compared with a net loss of $30.9M a year earlier
- Diluted EPS
- -$0.37
- compared with -$0.67 a year earlier